pentamidine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentamidine (PMD) is an anti-protozoa drug with potential anticancer activity." | 1.38 | Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis. ( Jiang, J; Liu, XS; Qiu, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, G | 1 |
| Jiang, J | 1 |
| Liu, XS | 1 |
1 other study available for pentamidine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cell Survival; Humans; K562 | 2012 |